Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score‐matched cohort study-Reference-Cited by-同舟云学术

Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score‐matched cohort study

Published:2021-09-23 Issue:3 Volume:196 Page:690-699
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Huang Wuqing¹²^ORCID,Sundquist Kristina²³⁴,Sundquist Jan²³⁴,Ji Jianguang²

Affiliation:

1. Department of Epidemiology and Health Statistics School of Public Health Fujian Medical University Fujian China

2. Department of Clinical Sciences Malmö Center for Primary Health Care Research Lund University Lund Sweden

3. Department of Family Medicine and Community Health Department of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York NY USA

4. Department of Functional Pathology Center for Community‐based Healthcare Research and Education (CoHRE) School of Medicine Shimane University Matsue Japan

Funder

Cancerfonden

Vetenskapsrådet

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17851

Reference43 articles.

1. DrugBank 5.0: a major update to the DrugBank database for 2018

2. Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?

3. Dipyridamole, cerebrovascular disease, and the vasculature

4. Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte Aggregates

5. Modulation of oxidative stress as an anticancer strategy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose acetylsalicylic acid for cancer prevention considering risk factors: a retrospective cohort study;Annals of Epidemiology;2023-08

2. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities;Pharmacology & Therapeutics;2022-12